Received Dec 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
The antigen component was reconstituted with sterile water instead of with the adjuvant component; The antigen component was reconstituted with sterile water instead of with the adjuvant component; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 13-DEC-2025, the patient received Shingrix. On 13-DEC-2025, after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: The antigen component was reconstituted with sterile water instead of with the adjuvant component) and inappropriate preparation of medication (Verbatim: The antigen component was reconstituted with sterile water instead of with the adjuvant component). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK receipt date: 16-DEC-2025 The reporter was a practice manager who stated that a patient had accidentally received a dose of Shingrix on 13-DEC-2025 that had been reconstituted incorrectly. The antigen component had been reconstituted with sterile water instead of with the adjuvant component. The batch number was not provided and a request for this information has been made.